Document:

Exhibit 10.1

 

BIMI
International Medical Inc. Announces Results of Special Meeting

 

NEW
YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”),
a leading healthcare products and services provider, today announced that shareholders have approved the two proposals voted on
at the Registrant’s special meeting of shareholders held on November 5, 2021.

 

The
first proposal is an amendment to the Registrant’s Certificate of Incorporation to increase the number of Registrant’s authorized
shares of common stock (the “Common Stock”) by 150,000,000 to 200,000,000. The second proposal is that the shareholders grant
discretionary authority to the board of directors of the Registrant (the “Board”) to amend the Registrant’s Certificate
of Incorporation to effect a reverse stock split of the Common Stock within the range of 1-2 to 1-5 to be determined by the Board and
with the reverse stock split to be effective at such time and date, if at all, as determined by the Board, but not later than the first
anniversary of its approval by the Shareholders.

 

“I
would like to thank our shareholders for their support in approving the two proposals. Increasing the number of common shares will allow
us to have sufficient shares to support future transactions”, said Mr. Tiewei Song, Chief Executive Officer and President of BIMI
International Medical Inc. 

 

About
BIMI International Medical Inc.

 

BIMI
International Medical Inc. was founded in 2006. The Company is now exclusively a healthcare products and provider, offering a broad range
of healthcare products and related services and operates five private hospitals in China. For more information, please visit www.usbimi.com.

 

Safe
Harbor Statement

 

Certain
matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but
not limited to, the Company’s ability to achieve profitable operations, its ability to continue to operate as a going concern,
its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of COVID-19, the demand for the Company’s
products and services in the People’s Republic of China, general economic conditions and other risk factors detailed in the Company’s
annual report and other filings with the United States Securities and Exchange Commission.

 

IR
Contact:

 

Dragon
Gate Investment Partners LLC

Tel: +1(646)-801-2803

Email: BIMI@dgipl.comExhibit 10.11

  

	 	Thomas
                                            L. Thimot
Chief Executive Officer
tomthimot@authid.ai

	 	 
	 	November 5, 2021

 

Phillip Kumnick

549 Quail Ridge Lane

St. Albans, Missouri 63073

 

Re: Your Ipsidy Inc. (the “Company”) Options Grant
dated as of May 5, 2021(“Option”)

 

Dear Phillip:

 

I refer to our discussions regarding the above
referenced Option and following our Board Meeting on October 25, 2021, at which an amendment to the Options was approved, I am writing
on behalf of the Company, to record the terms which have been agreed.

 

In consideration of our mutual agreements, set
forth below the following amendments to your Option are hereby agreed. Words and expressions defined in the Option shall bear the same
meaning in this letter.

 

		1.	You hereby agree to the cancellation of a total of 300,000 Shares under the Option comprising:

		a.	204,167 Shares under Section 5(d) of the Option; and

		b.	95,833 Shares under Section 5(c) of the Option.

 

		2.	The remaining Shares shall vest in accordance with Sections 5(a), (b), (c) or (e) of the Option, notwithstanding
non-continuation of service to the Company (other than for cause), and Section 5(f) of the Option is hereby amended by the deletion of
the second sentence and its replacement with the following:

 

“If any vesting condition is not
satisfied before the earlier of the expiration or termination date of this Option, or termination of the Optionee’s service to the
Company for Cause, the Option shall lapse as to the unvested Shares.

 

“Cause” shall mean you have:
(i) willfully failed to perform, or been grossly negligent with respect to, any material duties assigned to you as a Director, other than
due to a failure resulting from your disability; (ii) been convicted of, or pled guilty or no contest to, any felony or crime involving
immoral or unethical turpitude; (iii) committed an act of fraud, misappropriation, embezzlement or dishonesty with respect to the Company
or any of its affiliates; (iv) willfully violated any material Company policy; or (v)  breached any of the material terms of
the Invention Assignment & Confidentiality Agreement, the Company’s share dealing code, the Employee’s non-competition
agreement or any other reasonable policies of the Company where non-compliance would be materially detrimental to the Company and in the
case of clauses (i), (iv) and (v), to the extent such violation or breach is then curable, failed to cure such violation or breach (as
determined by the Board in good faith) during a thirty (30)-day period following the date on which the Company gives you written notice
of the breach.”

 

(For purposes of the foregoing, it is
acknowledged that the Option erroneously contains two Sections that are designated as “5(f),” and that the reference above
to Section 5(f) refers to the second such Section.)

 

    Ipsidy Inc. · 670 Long Beach Boulevard · Long Beach, New York 11561 · Tel +1 516 274 8700 · www.authid.ai

     

    

 

	 	Phillip L. Kumnick:Page 2
November 5, 2021

 

		3.	In addition, Section 7 of the Option is hereby deleted in its entirety and Section 8 of the Option is
hereby replaced in its entirety with the following:

 

“8. Death of
Optionee. If the Optionee shall die, Optionee's personal representative or the person entitled to Optionee's rights hereunder
may at any time prior to the expiration date of this Option exercise this Option and purchase Shares to the extent, but only to the
extent, that Optionee could have exercised this Option if Optionee were still alive; provided, in any case, that this Option may be
so exercised only to the extent that this Option has not previously been exercised by Optionee.”

 

		4.	In all other respects the terms of the Option shall remain in full force and effect.

 

Please sign and return a copy of this letter by way of confirmation
of your agreement to its terms.

  

	 	Sincerely,
	 	 
		Ipsidy Inc. dba authID.ai
	 	 
	 	/s/ Thomas L. Thimot
	 	Thomas L. Thimot CEO

 

	AGREED AND CONSENTED TO	 	 
	 	 	 
	/s/ Phillip L. Kumnick	 	 
	Phillip L. Kumnick	 	November 5, 2021

 

 

670
Long Beach Boulevard, · Long
Beach, New York 11561 ·.
Tel +1 516 274 8700 ·.
www.ipsidy.comExhibit 10.12

 

	 	 	Thomas L. Thimot

Chief Executive Officer

 tomthimot@authid.ai

	 	 	 
	 	 	November 5, 2021

 

Philip R. Broenniman

2130 Hermosa Drive

Boulder, Colorado 80304.

 

Re: Your Ipsidy Inc. (the “Company”) Options Grant
dated as of May 5, 2021(“Option”)

 

Dear Philip:

 

I refer to our discussions regarding the above
referenced Option and following our Board Meeting on October 25, 2021, at which an amendment to the Options was approved, I am writing
on behalf of the Company, to record the terms which have been agreed.

 

In consideration of our mutual agreements, set
forth below the following amendments to your Option are hereby agreed. Words and expressions defined in the Option shall bear the same
meaning in this letter.

 

		1.	You hereby agree to the cancellation of a total of 200,000 Shares under the Option comprising 200,000 Shares under Section 5(d) of
the Option

 

		2.	The remaining Shares shall vest in accordance with Sections 5(a), (b), (c), (d) or (e) of the Option,
notwithstanding non-continuation of service to the Company (other than for cause) and Section 5(f) of the Option is hereby amended by
the deletion of the second sentence and its replacement with the following:

 

“If any vesting condition is not
satisfied before the earlier of the expiration or termination date of this Option, or termination of the Optionee’s service to the
Company for Cause, the Option shall lapse as to the unvested Shares.

 

“Cause” shall mean you have:
(i) willfully failed to perform, or been grossly negligent with respect to, any material duties assigned to you as a Director, other than
due to a failure resulting from your disability; (ii) been convicted of, or pled guilty or no contest to, any felony or crime involving
immoral or unethical turpitude; (iii) committed an act of fraud, misappropriation, embezzlement or dishonesty with respect to the Company
or any of its affiliates; (iv) willfully violated any material Company policy; or (v)  breached any of the material terms of
the Invention Assignment & Confidentiality Agreement, the Company’s share dealing code, the Employee’s non-competition
agreement or any other reasonable policies of the Company where non-compliance would be materially detrimental to the Company and in the
case of clauses (i), (iv) and (v), to the extent such violation or breach is then curable, failed to cure such violation or breach (as
determined by the Board in good faith) during a thirty (30)-day period following the date on which the Company gives you written notice
of the breach.”

 

(For purposes of the foregoing, it is acknowledged that the
Option erroneously contains two Sections that are designated as “5(f),” and that the reference above to Section 5(f) refers
to the second such Section.)

 

    Ipsidy Inc. · 670 Long Beach Boulevard · Long Beach, New York 11561 · Tel +1 516 274 8700 · www.authid.ai

     

    

 

	 	 	Philip R. Broenniman:

Page 2

November 5, 2021

 

		3.	In addition, Section 7 of the Option is hereby deleted in its entirety and Section 8 of the Option is hereby replaced in its entirety
with the following:

 

“8. Death of Optionee. If the Optionee
shall die, Optionee’s personal representative or the person entitled to Optionee’s rights hereunder may at any time
prior to the expiration date of this Option exercise this Option and purchase Shares to the extent, but only to the extent, that
Optionee could have exercised this Option if Optionee were still alive; provided, in any case, that this Option may be so exercised
only to the extent that this Option has not previously been exercised by Optionee.”

 

		4.	In all other respects the terms of the Option shall remain in full force and effect.

 

Please sign and return a copy of this letter by way of confirmation
of your agreement to its terms.

 

	 	Sincerely,
	 	 
	 	Ipsidy Inc. dba authID.ai
	 	 
	 	/s/ Thomas L. Thimot
	 	Thomas L. Thimot CEO

 

AGREED AND CONSENTED TO

 

	/s/s Philip R. Broenniman	 
	Philip R. Broenniman	November 5, 2021

 

 

 

670 Long Beach Boulevard, ·
Long Beach, New York 11561 ·.
Tel +1 516 274 8700 ·.
www.ipsidy.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]